纖維蛋白原相關(guān)蛋白1(FGL1)活性蛋白
Active Fibrinogen Like Protein 1 (FGL1)
FGL-1; HFREP1; HP-041; LFIRE1; Hepassocin; Hepatocyte-derived fibrinogen-related protein 1; Liver fibrinogen-related protein 1
- 編號APD022Hu61
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 緩沖液成份PBS, pH7.4, containing 5% Trehalose.
- 性狀凍干粉
- 純度> 95%
- 等電點5.4
- 應(yīng)用Cell?culture;?Activity?Assays.
- 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 1440 ¥ 3600 ¥ 7200 ¥ 21600 ¥ 54000
- 欲了解實際交易價格和更多情況,請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
活性實驗
Fibrinogen Like Protein 1 (FGL1), also known as fibrinogen-related protein 1 or HFREP-1,?is a member of the fibrinogen family. FGL1 has multiple biological functions, which plays an important role in intercellular signaling, immune regulation, cell adhesion and angiogenesis. In addition, the expression of FGL1 protein is also up-regulated in tumor tissues, such as lung, prostate, melanoma, colorectal, breast cancer, and brain tumors, suggesting that it may play an important role in the development and progression of these diseases. Fibrinogen Alpha Chain (FGA) has been identified as an interactor of FGL1, thus a functional binding ELISA assay was conducted to detect the interaction of recombinant human FGL1 and recombinant mouse FGA. Briefly, biotin-linked FGL1 were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100 ul were then transferred to FGA-coated microtiter wells and incubated for 1h at 37℃. Wells were washed with PBST 3 times and incubation with Streptavidin-HRP for 30min, then wells were aspirated and washed 5 times. With the addition of substrate solution, wells were incubated 15-25 minutes at 37℃. Finally, add 50 μl stop solution to the wells and read at 450 nm immediately. The binding activity of recombinant human FGL1 and recombinant mouse FGA was shown in Figure 1, the EC50?for this effect is 0.07 ug/mL.
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月,-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當(dāng)?shù)臈l件下存儲,損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應(yīng)用(僅供研究使用,不用于臨床診斷!) |
APD022Hu61 | 纖維蛋白原相關(guān)蛋白1(FGL1)活性蛋白 | Cell?culture;?Activity?Assays. |
EPD022Hu41 | 纖維蛋白原相關(guān)蛋白1(FGL1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPD022Hu62 | 纖維蛋白原相關(guān)蛋白1(FGL1)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPD022Hu01 | 纖維蛋白原相關(guān)蛋白1(FGL1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAD022Hu01 | 纖維蛋白原相關(guān)蛋白1(FGL1)多克隆抗體 | WB,IHC |
LAD022Hu71 | 纖維蛋白原相關(guān)蛋白1(FGL1)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
LAD022Hu81 | 纖維蛋白原相關(guān)蛋白1(FGL1)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
MAD022Hu22 | 纖維蛋白原相關(guān)蛋白1(FGL1)單克隆抗體 | WB; IHC; ICC; IP. |
MAD022Hu23 | 纖維蛋白原相關(guān)蛋白1(FGL1)單克隆抗體 | WB; IHC; ICC; IP. |
MAD022Hu24 | 纖維蛋白原相關(guān)蛋白1(FGL1)單克隆抗體 | WB |
MAD022Hu21 | 纖維蛋白原相關(guān)蛋白1(FGL1)單克隆抗體 | WB; IHC |
SED022Hu | 纖維蛋白原相關(guān)蛋白1(FGL1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMD022Hu | 纖維蛋白原相關(guān)蛋白1(FGL1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSD022Hu01 | 纖維蛋白原相關(guān)蛋白1(FGL1)檢測試劑盒DIY材料(酶聯(lián)免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
J Hepatol. | The role of Hepassocin in the development of non-alcoholic fatty liver disease [Pubmed: 23792031] |
Diabetes Management | Serum hepassocin concentrations in diabetic patients with or without nonalcoholic fatty liver disease [Futuremedicine:Source] |
United States Patent Application | Compositions and Methods for Diagnosing Lung Cancer [y2016:0077095.html] |
Cell | Obesity Drives STAT-1-Dependent NASH and STAT-3-Dependent HCC [Doi: 10.1016/j.cell.2018.09.053] |
Liver Research | Do different bariatric surgery procedures impact hepassocin plasma levels in patients with type 2 diabetes mellitus? [] |
Impacts of Different Modes of Bariatric Surgery on Plasma Levels of Hepassocin in Patients with Diabetes Mellitus [] |